These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Talamonti M; Galluzzo M; Chiricozzi A; Quaglino P; Fabbrocini G; Gisondi P; Marzano AV; Potenza C; Conti A; Parodi A; Piaserico S; Bardazzi F; Argenziano G; Rongioletti F; Stingeni L; Micali G; Loconsole F; Rossi MT; Bongiorno MR; Feliciani C; Rubegni P; Amerio P; Fargnoli MC; Pigatto P; Savoia P; Nisticò SP; Giustini S; Carugno A; Cannavo' SP; Rech G; Prignano F; Offidani A; Lombardo M; Zalaudek I; Bianchi L; Peris K; ; Balestri R ; Bernardini N ; Belloni Fortini A ; Burlando M ; Caldarola G ; Campione E ; Cattaneo A ; Dapavo P ; Dastoli S ; De Simone C ; Di Nuzzo S ; Diotallevi F ; Fierro MT ; Franchi C ; Esposito M ; Foti C ; Gambini DM ; Gambardella A ; Girolomoni G ; Giunta A ; Guarneri C ; Gualdi G ; Hansel K ; Megna M ; Mugheddu C ; Musumeci ML ; Patrizi A ; Pellacani G ; Richetta AG ; Rosi E ; Sacchelli L ; Tiberio R ; Tilotta G ; Trovato E ; Venturini M ; Vezzoni R Expert Opin Biol Ther; 2021 Feb; 21(2):271-277. PubMed ID: 33216643 [No Abstract] [Full Text] [Related]
7. Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study. Kridin K; Schonmann Y; Damiani G; Peretz A; Onn E; Bitan DT; Cohen AD Dermatol Ther; 2021 Jul; 34(4):e15003. PubMed ID: 34033207 [TBL] [Abstract][Full Text] [Related]
9. Nineteen months into the pandemic, what have we learned about COVID-19-related outcomes in patients with psoriasis? Kridin K; Schonmann Y; Onn E; Bitan DT; Weinstein O; Shavit E; Cohen AD J Cosmet Dermatol; 2022 Dec; 21(12):6549-6553. PubMed ID: 36056782 [TBL] [Abstract][Full Text] [Related]
10. Effect of immunosuppressive drugs in immune-mediated inflammatory disease during the coronavirus pandemic. Giuliani F; Gualdi G; Amerio P Dermatol Ther; 2020 Nov; 33(6):e14204. PubMed ID: 32829511 [TBL] [Abstract][Full Text] [Related]
11. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19. Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Reilev M; Kristensen KB; Pottegård A; Lund LC; Hallas J; Ernst MT; Christiansen CF; Sørensen HT; Johansen NB; Brun NC; Voldstedlund M; Støvring H; Thomsen MK; Christensen S; Gubbels S; Krause TG; Mølbak K; Thomsen RW Int J Epidemiol; 2020 Oct; 49(5):1468-1481. PubMed ID: 32887982 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study. Bergman J; Ballin M; Nordström A; Nordström P Eur J Epidemiol; 2021 Mar; 36(3):287-298. PubMed ID: 33704634 [TBL] [Abstract][Full Text] [Related]
14. Characteristics and Clinical Outcomes of 116,539 Patients Hospitalized with COVID-19-Poland, March-December 2020. Gujski M; Jankowski M; Rabczenko D; Goryński P; Juszczyk G Viruses; 2021 Jul; 13(8):. PubMed ID: 34452324 [TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text]. Ladda M; Lynde C; Fleming P J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760 [TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting. Ghoreishi Amin N; Khosravi S; Atefi N; Seirafianpour F; Farhoodi S; Goodarzi A Immun Inflamm Dis; 2023 Nov; 11(11):e1063. PubMed ID: 38018599 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study. Yousaf A; Gayam S; Feldman S; Zinn Z; Kolodney M J Am Acad Dermatol; 2021 Jan; 84(1):70-75. PubMed ID: 32926977 [TBL] [Abstract][Full Text] [Related]
18. Drug utilization patterns and adherence in patients on systemic medications for the treatment of psoriasis: A retrospective, comparative cohort study. Dommasch ED; Lee MP; Joyce CJ; Garry EM; Gagne JJ J Am Acad Dermatol; 2018 Dec; 79(6):1061-1068.e1. PubMed ID: 29981385 [TBL] [Abstract][Full Text] [Related]
19. Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system. Erben Y; Franco-Mesa C; Gloviczki P; Stone W; Quinones-Hinojoas A; Meltzer AJ; Lin M; Greenway MRF; Hamid O; Devcic Z; Toskich B; Ritchie C; Lamb CJ; De Martino RR; Siegel J; Farres H; Hakaim AG; Sanghavi DK; Li Y; Rivera C; Moreno-Franco P; O'Keefe NL; Gopal N; Marquez CP; Huang JF; Kalra M; Shields R; Prudencio M; Gendron T; McBane R; Park M; Hoyne JB; Petrucelli L; O'Horo JC; Meschia JF J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1361-1370.e1. PubMed ID: 33836287 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 and psoriasis: biologic treatment and challenges. Ebrahimi A; Sayad B; Rahimi Z J Dermatolog Treat; 2022 Mar; 33(2):699-703. PubMed ID: 32598204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]